osimertinib
astrazeneca
['adaura', 'nsclc', 'sclc', 'osimertinib', 'aura ,(-laura)']
 #asco23 plenary session, presents #overallsurvival results of #adaura trial: adjuvant #osimertinib in resected stage ib-iiia #egfr mutant #nsclc improved #os hr: 0.49 5 yr os:
85% vs 73% for stage ii-iiia
88% vs 78% for stage ib-iiia 
Associate Professor/Thoracic Oncologist/Vice Chair-Education/#HemOnc Fellowship Director @MayoClinic FL/Assoc Editor @ASCO #Education #LungCancer الرئة #أورام